SSAnkang Health
English Español Português العربية
Consult Now
Home Services Hospitals Doctors Treatment & Verification Patient Stories Resources About FAQ Consult Now
EN ES PT AR
Home / Services / Stem Cell Therapy / Post-Stroke Recovery
Stem Cell Therapy

Post-Stroke Recovery

Combined IV/intrathecal MSC therapy with neurorehabilitation; observational improvement in hemiparesis and aphasia.

1
Treatment Options
4
Recommended Centers
$14,000
Starting From
7-21 days
Typical Wait

Treatment Plans for Post-Stroke Recovery

Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.

Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.

Why China for Post-Stroke Recovery

Combined Western/TCM rehabilitation + cell therapy programmes.

Recommended Hospitals for Post-Stroke Recovery

Hand-picked by case volume, outcomes, and international patient experience.

#1
Chinese PLA General Hospital (301)
Beijing

Chinese PLA General Hospital (301)

JCI ISO 9001
4,000
View Hospital
#2
Renji Hospital, Shanghai Jiao Tong University
Shanghai

Renji Hospital, Shanghai Jiao Tong University

JCI ISO 9001
2,000
View Hospital
#3
Peking Union Medical College Hospital
Beijing

Peking Union Medical College Hospital

JCI HIMSS Stage 7 ISO 9001
2,000
View Hospital
#4
Shanghai East Hospital, Tongji University
Shanghai

Shanghai East Hospital, Tongji University

JCI ISO 9001
1,500
View Hospital

About Post-Stroke Recovery

Common Symptoms
  • Hemiparesis
  • Aphasia
  • Dysphagia
  • Cognitive impairment
Common Causes
  • Ischemic stroke
  • Hemorrhagic stroke
Diagnostic Methods
  • Brain MRI
  • NIHSS score
  • Modified Rankin Scale

Evidence & Reference Standards

Our stem-cell and regenerative-medicine pathways align with international cell-therapy standards:

ISSCR · International
Guidelines for Stem Cell Research & Translation
Global reference for clinical translation, informed consent and unproven-therapy positioning — sets the boundary of what we coordinate.
FDA · United States
Regenerative Medicine — Cellular & Gene Therapy
U.S. regulatory framework for HCT/P products informs our screening of Chinese centre protocols against international safety standards.
WHO · World Health Organization
Cell, Tissue & Organ Transplantation Standards
International donor-screening and traceability principles reflected in the partner hospitals we recommend.
NIH · United States
Stem Cell Information
NIH primer on validated vs investigational uses — used to set realistic expectations in our pre-treatment counselling.

SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.

Related Conditions

Spinal Cord Injury
NMPA-regulated UC-MSC + neural progenitor cell trials at 301 Hospital and Tongji…
Knee Osteoarthritis (Cell Therapy)
Intra-articular UC-MSC injection as alternative to knee replacement for early-to…
Multiple Sclerosis
Autologous hematopoietic stem cell transplant (AHSCT) and UC-MSC therapy at top …
Lupus (SLE) — Stem Cell Therapy
Autologous HSCT and UC-MSC therapy for refractory lupus nephritis; Chinese landm…